Data from Phase 3 Trial of Genasense(R) Confirm Extended Durability of...

PR Newswire;  September 19, 2005 ;     700+ words ......plus chemotherapy for patients with relapsed or refractory...lymphocytic leukemia (CLL). In addition to the...Phase 3 trial, 241 patients with relapsed or refractory CLL were randomly assigned...immune functions. Patients with CLL typically develop...

Updated Analysis from Phase 3 Trial of Genasense(R) in CLL Shows...

PR Newswire;  May 13, 2005 ;     700+ words ......sodium) Injection in patients with relapsed or...lymphocytic leukemia (CLL). Preliminary results...standard treatment for CLL that had included...hundred forty one patients were randomized to...immune functions. Patients with CLL typically develop...

Chronic Lymphocytic Leukemia (CLL) Patients Reach Five-Year Survival...

PR Newswire;  May 3, 2005 ;     700+ words ......of detectable diseased cells in patients with CLL is associated with a prolonged...appears to extend the lives of most CLL patients beyond five years, said Dr. Hillmen...took place July 1996 to May 2003. CLL patients who relapse from or are refractory...

Mayo Clinic Reports Some Chronic Leukemia Patients May Improve by Taking...

AScribe Health News Service;  December 13, 2005 ;     514 words ......EGCG kills leukemia cells from patients with CLL in the test tube by interrupting...watchful waiting with early-stage CLL patients. However, new tests, new medications...agent may provide new hope for CLL patients. Other Mayo Clinic researchers...

Genta Completes Appeal of FDA Decision for Genasense(R) in CLL.

PR Newswire;  October 25, 2007 ;     700+ words ......plus chemotherapy for patients with relapsed/refractory...lymphocytic leukemia (CLL). In December 2006...pivotal Phase 3 trial, patients with relapsed or refractory CLL were randomly assigned...immune functions. Patients with CLL typically develop...

Factors affecting (131 I)-Lym-1 pharmacokinetics and radiation dosimetry...

The Journal of Nuclear Medicine;  August 1, 1999 ;     700+ words ......and LD trials, and for NHL and CLL patients in the LD trial, except that the...liver radiation dose was more in patients with CLL. Otherwise, radiation dosimetry...done on 6 patients, 3 NHL and 3 CLL patients. Before treatment, all but 1 patient...

Phase 3 Trial of Genasense(R) Plus Chemotherapy in Patients with Advanced...

PR Newswire;  November 9, 2004 ;     700+ words ......sodium) Injection in patients with relapsed or...lymphocytic leukemia (CLL) met its primary...In this study, patients who received Genasense...standard treatment for CLL that had included...hundred forty one patients were randomized...immune functions. Patients with CLL ...

MabThera Improves Response in Patients With Most Common Form of Adult...

PR Newswire Europe;  December 11, 2007 ;     497 words ......Seen in Untreated and Relapsed CLL Patients For non-US media only Abstract...demonstrating the efficacy of MabThera in CLL patients and highlight the impact MabThera...MabThera maintenance therapy in CLL patients, as all responding patients in...

Single-Agent Activity of Genta's Lead Anticancer Compound, Genasense(TM),...

PR Newswire;  December 9, 2002 ;     700+ words ......as a single agent in patients with advanced chronic lymphocytic leukemia (CLL). The results were presented...kill leukemia cells in patients with CLL. This unexpected activity...expression of Bcl-2. Patients with CLL typically have very high...

ASH Presentations Affirm Importance of Genasense(R) Target in CLL.

PR Newswire;  December 7, 2004 ;     700+ words ......severe reactions associated with rituximab in CLL patients. In this ongoing trial, 20 patients with CLL received Genasense at a dose of 1.5 mg/kg...reduce the incidence of this reaction in patients with CLL. (Chanan-Khan AA et al., abstract #4827...

Treatment with Subcutaneous (SC) MabCampath(R) (alemtuzumab) is Effective...

PR Newswire Europe;  December 12, 2005 ;     700+ words ......historical series of patients receiving intravenous...lymphocytic leukemia (CLL). The results presented...nearly half of all patients treated with SC...marrow assessments). Patients failing to achieve...Lymphocytic Leukemia (CLL) CLL is the most...antibody approved for CLL and ...

TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic...

PR Newswire;  December 10, 2007 ;     700+ words ......an FDA-approved therapy for patients with CLL. TREANDA(R) is a novel investigational...remissions in treatment-naive patients with CLL, said Dr. Wolfgang Knauf, Onkologische...first-line chemotherapy option for patients with CLL. Bendamustine demonstrated significantly...

Study Defines New Endpoint in the Treatment of CLL.

PR Newswire;  December 8, 2003 ;     700+ words ......in the blood and bone marrow of patients with CLL is a realistic goal, according...total of 91 relapsed or refractory CLL patients received a median of 12 weeks...first drug with proven efficacy in CLL patients who have failed both alkylating...

Randomized Phase III Trial Shows Efficacy of Campath(R) Following...

PR Newswire;  June 17, 2003 ;     700+ words ......chronic lymphocytic leukemia (CLL) patients in remission demonstrated a promising...dose for Campath consolidation in patients with CLL. This is the first presentation...drug with proven efficacy in B-CLL patients who have failed both alkylating...

Data From Numerous Clinical Studies Cite Activity of Nipent(R) Combination...

PR Newswire;  December 8, 2003 ;     700+ words ......Response data is available for 20 patients with CLL. Using National Cancer Institute...were infrequent. For the 20 patients with CLL, grade 3/4 toxicities included...enrolled 25 previously untreated patients with CLL. Each patient received a combination...